| 7495020 |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
Alan D. Adams, Joel Berger, James F. Dropinski, Alexander Elbrecht, Kun Liu +4 more |
2009-02-24 |
| 7442701 |
Amino-heterocycles as VR-1 antagonists for treating pain |
Peter Blurton, Frank Burkamp, Stephen Robert Fletcher, Gregory John Hollingworth, Edward Giles Mciver +2 more |
2008-10-28 |
| 7329659 |
Substituted-1-phthalazinamines as vr-1 antagonists |
Peter Blurton, Frank Burkamp, Stephen Robert Fletcher, Edward Giles Mciver |
2008-02-12 |
| 7285563 |
Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain |
Rebecca Brown, Victoria Alexandra Doughty, Gregory John Hollingworth, Matthew Lindon, Christopher Moyes +1 more |
2007-10-23 |
| 7125865 |
Therapeutic compounds for treating dyslipidemic conditions |
Alan D. Adams, Ahren Green, Shaei Y. Huang, Bruno Tse, Clare E. Gutteridge +1 more |
2006-10-24 |
| 7091230 |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
Alan D. Adams, Joel Berger, James F. Dropinski, Alexander Elbrecht, Kun Liu +4 more |
2006-08-15 |
| 6908934 |
Therapeutic compounds for treating dyslipidemic conditions |
Alan D. Adams, Aileen Bouffard, James F. Dropinski, Clare E. Gutteridge, Weiguo Lui +3 more |
2005-06-21 |
| 6852738 |
Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
John J. Acton, III |
2005-02-08 |
| 6569879 |
Aryloxyacetic acids for diabetes and lipid disorders |
Kun Liu, Libo Xu |
2003-05-27 |
| 5840835 |
Inhibitors of peptide binding to MHC class II proteins |
Alan D. Adams |
1998-11-24 |
| 5817757 |
Inhibitors of peptide binding to MHO class II proteins |
Alan D. Adams, Victoria K. Lombardo, Richard L. Tolman |
1998-10-06 |
| 5719296 |
Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
John J. Acton, III, Alan D. Adams, Jeffrey D. Hermes, William H. Parsons, Peter J. Sinclair |
1998-02-17 |
